eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 6 18-6, 1998, Pages

  Everett, Allen D ^a,d   Le Cras, Timothy D ^a,b   Xue, Chun ^a,c   Johns, Roger A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Children's Hospital Colorado   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Congenital heart disease; Endothelial nitric oxide synthase; Proliferating cell nuclear antigen; Shunt

Indexed keywords

ALPHA ACTIN; BROXURIDINE; CYCLINE; DNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; BLOOD VESSEL WALL; BODY WEIGHT; CELL PROLIFERATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; HEART WEIGHT; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG BLOOD FLOW; LUNG WEIGHT; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY DISEASE; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031798967     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.6.l1058     Document Type: Article

References (34)

1. Bevan, J. A., G. Kaley, and G. M. Rubanyi. Flow-Dependent Regulation of Vascular Function. New York: Oxford Univ. Press, 1995.
2. Burke-Wolin, T., C. J. Abate, M. S. Wolin, and G. H. Gurtner. Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3′,5′-cyclic monophosphate. Am. J. Physiol. 261 (Lung Cell. Mol. Physiol. 5): L393-L398, 1991.
3. Campbell, M. Incidence of cardiac malformations at birth and later, and neonatal mortality. Br. Heart J. 35: 189-200, 1973.
4. Carey, A. V., R. M. Carey, and R. A. Gomez. Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19, Suppl. 2: II168-II175, 1992.
5. Chen, Y., R. J. Torry, G. L. Baumbach, and R. J. Tomanek. Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H2132-H2137, 1994.
6. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537, 1993.
7. Church, G. M., and W. Gilbert. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81: 1991-1995, 1974.
8. Davidson, D., and A. Eldemerdash. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated neonatal guinea pig lung. Pediatr. Res. 29: 538-542, 1991.
9. Desanti, A. M., E. M. McDowell, and J. M. Strum. Airway branching patterns and cytodifferentiation in cultured fetal hamster lung. Tissue Cell 24: 853-868, 1992.
10. Everett, A. D., A. Tufro-McReddie, A. Fisher, and R. A. Gomez. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-B1 expression. Hypertension 23: 587-592, 1994.
11. Fineman, J. R., M. A. Heymann, and S. J. Soifer. N-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H299-H306, 1991.
12. Friedli, B., G. Kent, and B. S. L. Kidd. The effect of increased pulmonary blood flow on the pulmonary vascular bed in pigs. Pediatr. Res. 9: 547-553, 1975.
13. Fullerton, D. A., M. B. Mitchell, D. N. Jones, A. Maki, and R. C. McIntyre. Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow. J. Thorac. Cardiovasc. Surg. 111: 190-197, 1996.
14. Garcia, R., and S. Diebold. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc. Res. 24: 430-432, 1990.
15. Ha, B., C. L. Lucus, G. W. Henry, E. G. Frantz, J. I. Ferreiro, and B. R. Wilcox. Effects of chronically elevated pulmonary arterial pressure and flow on right ventricular afterload. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H155-H165, 1994.
16. Haworth, S. G. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am. J. Cardiol. 51: 265-272, 1983.
17. Heath, D., and J. E. Edwards. The pathology of hypertensive pulmonary vascular disease. Circulation 18: 533-537, 1958.
18. Hopkins, R. A. The pathophysiology of pulmonary vascular disease associated with congenital cardiac lesions. In: Ventricular/ Vascular Coupling: Clinical, Physiological and Engineering Aspects. New York: Springer-Verlag, 1987, p. 42-78.
19. Ishida, A., T. Sasaguri, C. Kosaka, H. Nojima, and J. Ogata. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/ Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272: 10050-10057, 1997.
20. Kim, H., H. Yeger, R. Han, M. Wallace, B. Goldstein, and D. Rotin. Expression of LAR-PTP2 in rat lung is confined to proliferating epithelia lining the airways and air sacs. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L566-L576, 1996.
21. Le Cras, T. D., R. C. Tyler, M. P. Horan, K. G. Morris, I. F. McMurtry, R. A. Johns, and S. H. Abman. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the rat lung. J. Clin. Invest. 101: 795-801, 1998.
22. Le Cras, T. D., C. Xue, A. Rengasamy, and R. A. Johns. Chronic hypoxia upregulates endothelial and inducible nitric oxide synthase gene and protein expression in rat lung. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L164-L170, 1996.
23. Lloyd-Jones, D. M., and K. D. Bloch. The vascular biology of nitric oxide and its role in atherogenesis. Annu. Rev. Med. 47: 365-375, 1996.
24. Meyrick, B., and L. Reid. Ultrastructural features of the distended pulmonary arteries of the normal rat. Anat. Rec. 193: 71-98, 1979.
25. Nadas, A. S., and D. C. Fyler. Atrial septal defects. In: Pediatric Cardiology, edited by A. S. Nadas and D. C. Fyler. Philadelphia, PA: Saunders, 1972.
26. Naduad, S., M. Philippe, J. Arnal, J. Michel, and F. Soubier. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ. Res. 79: 857-863, 1996.
27. Rizvi, M. A., and P. R. Myers. Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J. Mol. Cell. Cardiol. 29: 1779-1789, 1997.
28. Ruzicka, M., B. Yuan, E. Harmsen, and F. H. H. Leenen. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Circulation 87: 921-930, 1993.
29. Sessa, W. C., K. Pritchard, N. Seyedi, J. Wang, and T. H. Hintze. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353, 1994.
30. Shaul, P. W., A. J. North, T. S. Brannon, K. Ujiie, L. B. Wells, P. A. Nisen, C. J. Lowenstein, S. H. Snyder, and R. A. Star. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am. J. Respir. Cell Mol. Biol. 13: 167-174, 1995.
31. Xue, C., and R. A. Johns. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333: 1642-1644, 1995.
32. Xue, C., and R. A. Johns. Upregulation of nitric oxide synthetase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. Hypertension 28: 743-753, 1996.
33. Xue, C., P. R. Reynolds, and R. A. Johns. Developmental expression of NOSs in fetal rat lung: implications for transitional circulation and pulmonary angiogenesis. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L88-L100, 1996.
34. Yamaki, S., T. Horiuchi, K. Miura, Y. Suzuki, E. Ishizawa, and T. Takahashi. Pulmonary vascular disease in secundum atrial septal defect with pulmonary hypertension. Chest 89: 694-698, 1986.